Xiao‐Yuan Mao

3.9k total citations
99 papers, 3.0k citations indexed

About

Xiao‐Yuan Mao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Xiao‐Yuan Mao has authored 99 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 19 papers in Pulmonary and Respiratory Medicine and 19 papers in Cancer Research. Recurrent topics in Xiao‐Yuan Mao's work include Ferroptosis and cancer prognosis (19 papers), Neuroscience and Neuropharmacology Research (15 papers) and MicroRNA in disease regulation (12 papers). Xiao‐Yuan Mao is often cited by papers focused on Ferroptosis and cancer prognosis (19 papers), Neuroscience and Neuropharmacology Research (15 papers) and MicroRNA in disease regulation (12 papers). Xiao‐Yuan Mao collaborates with scholars based in China, United States and United Kingdom. Xiao‐Yuan Mao's co-authors include Hong‐Hao Zhou, Zhaoqian Liu, Weilin Jin, Ji‐Ye Yin, Qianyi Sun, Xi Li, Qi-Wen Guan, Xixi Yin, Yonggang Cao and Zhibin Wang and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Xiao‐Yuan Mao

95 papers receiving 2.9k citations

Peers

Xiao‐Yuan Mao
Amalia M. Dolga Netherlands
Gu Seob Roh South Korea
Tao Jiang China
Xin Tian China
Klaus van Leyen United States
Ki Whan Hong South Korea
Hildegard M. Schuller United States
Amalia M. Dolga Netherlands
Xiao‐Yuan Mao
Citations per year, relative to Xiao‐Yuan Mao Xiao‐Yuan Mao (= 1×) peers Amalia M. Dolga

Countries citing papers authored by Xiao‐Yuan Mao

Since Specialization
Citations

This map shows the geographic impact of Xiao‐Yuan Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐Yuan Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐Yuan Mao more than expected).

Fields of papers citing papers by Xiao‐Yuan Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao‐Yuan Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐Yuan Mao. The network helps show where Xiao‐Yuan Mao may publish in the future.

Co-authorship network of co-authors of Xiao‐Yuan Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao‐Yuan Mao. A scholar is included among the top collaborators of Xiao‐Yuan Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao‐Yuan Mao. Xiao‐Yuan Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liu, Yuqing, Lei Wu, Weijun Peng, & Xiao‐Yuan Mao. (2024). Glial polarization in neurological diseases: Molecular mechanisms and therapeutic opportunities. Ageing Research Reviews. 104. 102638–102638. 5 indexed citations
3.
Cao, Danfeng, Xinyu Zhou, Qian Guo, et al.. (2024). Unveiling the role of histone deacetylases in neurological diseases: focus on epilepsy. Biomarker Research. 12(1). 142–142. 30 indexed citations
4.
Cao, Danfeng, Kai Zhang, Xinyu Zhou, et al.. (2024). Inhibition of lysyl oxidase by pharmacological intervention and genetic manipulation alleviates epilepsy-associated cognitive disorder. Brain Research Bulletin. 210. 110928–110928. 1 indexed citations
5.
Zheng, Juyan, Tao Zhu, Wei Zhuo, et al.. (2023). eIF3a sustains non-small cell lung cancer stem cell-like properties by promoting YY1-mediated transcriptional activation of β-catenin. Biochemical Pharmacology. 213. 115616–115616. 9 indexed citations
6.
Xiao, Qi, Chen‐Xue Mao, Ying Gao, et al.. (2023). Establishing a Prediction Model for the Efficacy of Platinum—Based Chemotherapy in NSCLC Based on a Two Cohorts GWAS Study. Journal of Clinical Medicine. 12(4). 1318–1318. 1 indexed citations
7.
She, Lei, Xiao‐Yuan Mao, Lin Su, & Zhaoqian Liu. (2023). Prognostic evaluation of patients with glioblastoma using a new score prediction model. European Journal of Surgical Oncology. 49(9). 106902–106902. 1 indexed citations
8.
Luo, Jia, Ling Chen, Wenjuan Ma, et al.. (2022). PARPi treatment enhances radiotherapy-induced ferroptosis and antitumor immune responses via the cGAS signaling pathway in colorectal cancer. Cancer Letters. 550. 215919–215919. 58 indexed citations
9.
Gao, Jingquan, Peng Wang, Junwei Yan, et al.. (2021). Shear Stress Rescued the Neuronal Impairment Induced by Global Cerebral Ischemia Reperfusion via Activating PECAM-1-eNOS-NO Pathway. Frontiers in Cell and Developmental Biology. 8. 631286–631286. 11 indexed citations
10.
Guan, Qi-Wen, et al.. (2021). Ferrostatin-1 obviates seizures and associated cognitive deficits in ferric chloride-induced posttraumatic epilepsy via suppressing ferroptosis. Free Radical Biology and Medicine. 179. 109–118. 48 indexed citations
11.
Yin, Xixi, Qin Li, Qi-Wen Guan, et al.. (2020). Neuroprotective Effects of the Anti-cancer Drug Lapatinib Against Epileptic Seizures via Suppressing Glutathione Peroxidase 4-Dependent Ferroptosis. Frontiers in Pharmacology. 11. 601572–601572. 42 indexed citations
12.
Yang, Nan, Danfeng Cao, Xixi Yin, Hong‐Hao Zhou, & Xiao‐Yuan Mao. (2020). Lysyl oxidases: Emerging biomarkers and therapeutic targets for various diseases. Biomedicine & Pharmacotherapy. 131. 110791–110791. 37 indexed citations
13.
Wang, Xu, Zhibin Wang, Chao Luo, et al.. (2019). The Prospective Value of Dopamine Receptors on Bio-Behavior of Tumor. Journal of Cancer. 10(7). 1622–1632. 61 indexed citations
14.
Wang, Zhibin, Junyan Liu, Xiaojing Xu, et al.. (2019). Neurodegeneration with brain iron accumulation: Insights into the mitochondria dysregulation. Biomedicine & Pharmacotherapy. 118. 109068–109068. 31 indexed citations
15.
Li, Qin, et al.. (2018). 12/15 lipoxygenase: A crucial enzyme in diverse types of cell death. Neurochemistry International. 118. 34–41. 44 indexed citations
16.
Mao, Xiao‐Yuan, et al.. (2017). Live or let die: Neuroprotective and anti-cancer effects of nutraceutical antioxidants. Pharmacology & Therapeutics. 183. 137–151. 38 indexed citations
17.
Gao, Yuanfeng, Tao Zhu, Chen‐Xue Mao, et al.. (2016). PPIC, EMP3 and CHI3L1 Are Novel Prognostic Markers for High Grade Glioma. International Journal of Molecular Sciences. 17(11). 1808–1808. 41 indexed citations
18.
Gao, Yuanfeng, Zhibin Wang, Tao Zhu, et al.. (2016). A critical overview of long non-coding RNA in glioma etiology 2016: an update. Tumor Biology. 37(11). 14403–14413. 17 indexed citations
19.
Mao, Xiao‐Yuan, Xiaolei Li, Ying Ma, et al.. (2015). Baicalin alleviates diabetes-associated cognitive deficits via modulation of mitogen-activated protein kinase signaling, brain-derived neurotrophic factor and apoptosis. Molecular Medicine Reports. 12(4). 6377–6383. 40 indexed citations
20.
Qu, Jian, Ying Zhang, Xiao‐Yuan Mao, et al.. (2013). Gene‐Wide Tagging Study of the Association Between KCNT1 Polymorphisms and the Susceptibility and Efficacy of Genetic Generalized Epilepsy in Chinese Population. CNS Neuroscience & Therapeutics. 20(2). 140–146. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026